Itau Unibanco Holding SA (NYSE:ITUB) had its price objective cut by JPMorgan Chase & Co. from $17.00 to $14.00 in a report released on Wednesday. JPMorgan Chase & Co. currently has an overweight rating on the stock. On Thursday shares of Itau Unibanco Holding SA (ADR) (NYSE:ITUB) closed at $12.70. Company’s sales growth for last 5 years was 14.60% and EPS growth for next 5 years is recorded as 17.50%.
Overstock.com Inc. (NASDAQ:OSTK) reported fourth-quarter net income of $1.4 million. On a per-share basis, the Salt Lake City-based company said it had profit of 6 cents. The online discount retailer posted revenue of $470.4 million in the period. For the year, the company reported profit of $8.9 million, or 36 cents per share. Revenue was reported as $1.5 billion.Overstock.com Inc. (NASDAQ:OSTK) in last trading activity advanced 1.83% to close at $23.32. Company weekly performance is 4.34% while its quarterly performance stands at 1.13%. Overstock.com Inc. (NASDAQ:OSTK) is -19.42% away from its 52 week high.
Saul Centers, Inc. (NYSE:BFS), announced on 15 January the income tax treatment of its 2014 dividends. The Company declared and paid four quarterly dividends totaling $1.56 per share of Common Stock during 2014. For tax purposes, 100.0% of the dividends ($1.56 per common share) are characterized as ordinary income. On last trading day Saul Centers Inc. (NYSE:BFS) advanced 0.79% to close at $60.30. Its volatility for the week is 2.03% while volatility for the month is 1.98%. BFS’s sales growth for past 5 years was 4.30% and its EPS growth for past 5 years was -17.30%. Saul Centers Inc. (NYSE:BFS) monthly performance is 3.70%.
Heritage Financial Group, Inc. (NASDAQ:HBOS) on 22 January announced Net income of $2.5 million or $0.28 per diluted share, up 27% from $2.0 million or $0.26 per diluted share for the linked quarter, but down 27% from $3.4 million or $0.45 per diluted share for the year-earlier quarter. Heritage Financial Group, Inc. (NASDAQ:HBOS) has 1.90% insider ownership while its institutional ownership stands at 64.00%. In last trading activity company’s stock closed at $23.89.
CorMedix Inc. (NYSEMKT:CRMD) announced that the U.S. Food and Drug Administration (FDA) has designated the company’s lead product candidate, Neutrolin Catheter Lock Solution, as a Qualified Infectious Disease Product (QIDP) for oncology, hemodialysis and intensive care unit patients, where catheter-related blood stream infections and clotting can be life-threatening. On last trading day CorMedix, Inc. (NYSEMKT:CRMD) advanced 22.94% to close at $2.84. Its volatility for the week is 11.58% while volatility for the month is 10.45%. CRMD’s EPS growth for past 5 years was 4.10%. CorMedix, Inc. (NYSEMKT:CRMD) monthly performance is 57.78%.